Bone

Role of chromatin modulator Dpy30 in osteoclast differentiation and function.  159. 2022

Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women.  123:191-195. 2019

Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.  119:82-86. 2019

Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies.  116:58-66. 2018

Quality in dual-energy X-ray absorptiometry scans.  104:13-28. 2017

NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.  101:236-244. 2017

Cardiac actions of fibroblast growth factor 23.  100:69-79. 2017

Tgfbr2 is required in osterix expressing cells for postnatal skeletal development.  97:54-64. 2017

Cortical bone deficit and fat infiltration of bone marrow and skeletal muscle in ambulatory children with mild spastic cerebral palsy..  94:90-97. 2017

Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.  93:113-124. 2016

Admixture mapping of serum vitamin D and parathyroid hormone concentrations in the African American-Diabetes Heart Study.  87:71-77. 2016

Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans.  78:174-185. 2015

Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.  81:746-756. 2015

Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation.  66:111-120. 2014

Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.  57:10-17. 2013

Osteoporosis medication adherence: Physician perceptions vs. patients' utilization.  55:1-6. 2013

Bone healing by endogenous stem cell mobilization.  51:635. 2012

Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).  50:1288-1293. 2012

Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect.  50:1012-1018. 2012

Corrigendum to "Bisphosphonates and glucocorticoid osteoporosis in men: Results of a randomized controlled trial comparing zoledronic acid with risedronate" [Bone 50 (2012) 289-295].  50:811. 2012

Bisphosphonates and glucocorticoid osteoporosis in men: Results of a randomized controlled trial comparing zoledronic acid with risedronate.  50:289-295. 2012

Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan.  50:870-875. 2012

Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: A pilot study.  50:23-27. 2012

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).  49:493-498. 2011

Corrigendum to "Cost burden of second fracture in the US Health System" [Bone 48 (2011) 828-836].  48:1429. 2011

Cost burden of second fracture in the US Health System.  48:828-836. 2011

Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach.  49:356-367. 2011

Deletion of insulin receptor in chondrocytes sensitizes IGF-1 signaling and action.  47:s446. 2010

Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.  47:301-308. 2010

Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth.  47:93-101. 2010

Distribution of type I collagen morphologies in bone: Relation to estrogen depletion.  46:1349-1354. 2010

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.  46:929-934. 2010

NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation.  45:579-589. 2009

Hypoxia and HIF-1α expression in the epiphyseal cartilage following ischemic injury to the immature femoral head.  45:280-288. 2009

Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.  45:346-356. 2009

Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo.  44:528-536. 2009

Congenital pseudarthrosis of neurofibromatosis type 1: Impaired osteoblast differentiation and function and altered NF1 gene expression.  44:243-250. 2009

DSPP effects on in vivo bone mineralization.  43:983-990. 2008

Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation.  40:1502-1516. 2007

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.  40:1238-1243. 2007

Evolving gene therapy approaches for osteosarcoma using viral vectors: Review.  40:797-812. 2007

Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.  38:497-508. 2006

Silk implants for the healing of critical size bone defects.  37:688-698. 2005

Identification of the type II Na⁺-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice.  29:467-476. 2001

Human osteosarcomas inhibit hematopoietic colony formation: Partial reversal by antibody to transforming growth factor-β1.  21:353-361. 1997

Ceramics: Past, present, and future.  19:S121-S128. 1996